Wall Street analysts expect Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to report $533.39 million in sales for the current fiscal quarter, according to Zacks. Ten analysts have provided estimates for Allscripts Healthcare Solutions’ earnings, with the highest sales estimate coming in at $552.10 million and the lowest estimate coming in at $508.70 million. Allscripts Healthcare Solutions reported sales of $415.10 million in the same quarter last year, which indicates a positive year over year growth rate of 28.5%. The business is scheduled to report its next quarterly earnings results on Thursday, May 3rd.
On average, analysts expect that Allscripts Healthcare Solutions will report full-year sales of $533.39 million for the current fiscal year, with estimates ranging from $2.16 billion to $2.22 billion. For the next fiscal year, analysts forecast that the business will post sales of $2.29 billion per share, with estimates ranging from $2.22 billion to $2.34 billion. Zacks’ sales averages are a mean average based on a survey of analysts that that provide coverage for Allscripts Healthcare Solutions.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings data on Thursday, February 15th. The software maker reported $0.18 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.18. Allscripts Healthcare Solutions had a negative net margin of 10.88% and a positive return on equity of 7.36%. The business had revenue of $547.00 million for the quarter, compared to analyst estimates of $524.05 million. During the same period in the prior year, the business posted $0.14 earnings per share. Allscripts Healthcare Solutions’s revenue was up 27.5% compared to the same quarter last year.
In related news, President Richard J. Poulton sold 15,000 shares of the firm’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $13.53, for a total transaction of $202,950.00. Following the sale, the president now directly owns 505,920 shares in the company, valued at $6,845,097.60. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Brian Farley sold 5,000 shares of the firm’s stock in a transaction on Wednesday, March 14th. The stock was sold at an average price of $13.73, for a total transaction of $68,650.00. Following the sale, the executive vice president now owns 240,672 shares in the company, valued at $3,304,426.56. The disclosure for this sale can be found here. Company insiders own 0.75% of the company’s stock.
Large investors have recently modified their holdings of the stock. Fuller & Thaler Asset Management Inc. raised its holdings in shares of Allscripts Healthcare Solutions by 1.0% during the third quarter. Fuller & Thaler Asset Management Inc. now owns 5,062,035 shares of the software maker’s stock worth $72,033,000 after acquiring an additional 49,823 shares during the period. Principal Financial Group Inc. raised its holdings in shares of Allscripts Healthcare Solutions by 30.1% during the third quarter. Principal Financial Group Inc. now owns 1,003,690 shares of the software maker’s stock worth $14,283,000 after acquiring an additional 232,209 shares during the period. Neuberger Berman Group LLC raised its holdings in shares of Allscripts Healthcare Solutions by 5.5% during the third quarter. Neuberger Berman Group LLC now owns 3,676,088 shares of the software maker’s stock worth $52,311,000 after acquiring an additional 190,158 shares during the period. Janney Montgomery Scott LLC acquired a new stake in shares of Allscripts Healthcare Solutions during the third quarter worth $710,000. Finally, Cubist Systematic Strategies LLC raised its holdings in shares of Allscripts Healthcare Solutions by 67,189.1% during the third quarter. Cubist Systematic Strategies LLC now owns 30,953 shares of the software maker’s stock worth $440,000 after acquiring an additional 30,907 shares during the period.
Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at $13.35 on Friday. Allscripts Healthcare Solutions has a twelve month low of $11.25 and a twelve month high of $16.13. The firm has a market cap of $2,463.19, a P/E ratio of 28.98, a P/E/G ratio of 1.76 and a beta of 1.20. The company has a quick ratio of 0.97, a current ratio of 0.97 and a debt-to-equity ratio of 1.33.
WARNING: “Allscripts Healthcare Solutions Inc (MDRX) Expected to Announce Quarterly Sales of $533.39 Million” was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://www.chaffeybreeze.com/2018/03/16/allscripts-healthcare-solutions-inc-mdrx-expected-to-announce-quarterly-sales-of-533-39-million.html.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.